“Deucravacitinib Improves Psoriasis Symptoms and Signs Diary Domain Scores in Patients With Moderate to Severe Plaque Psoriasis: Results From the Phase 3 POETYK PSO-1 and POETYK PSO-2 Studies”, J of Skin, vol. 5, no. 6, p. s38, Nov. 2021, doi: 10.25251/skin.5.supp.38.